by Pill Pals | Mar 5, 2025 | News
Summary Company Announcement Date: March 05, 2025 FDA Publish Date: March 05, 2025 Product Type: Animal & VeterinaryFood & Beverages Livestock Feed Reason for Announcement: Recall Reason Description Elevated levels or deficient levels of nutrients which may...
by Pill Pals | Mar 5, 2025 | News
Aimovig (erenumab-aooe)Wrong strengthFDA decided that no action is necessary at this time based on available information.Aimovig (erenumab-aooe)Product preparation error The carton labeling, “Dosage and Administration”, “Patient Counseling Information”, “Patient...
by Pill Pals | Mar 5, 2025 | News
This communication was initially issued as part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has since determined that this device may cause temporary or reversible health problems, or—though unlikely—serious health problems. This...
by Pill Pals | Mar 5, 2025 | News
Actemra (tocilizumab) Hepatitis B reactivation FDA determined that no action is necessary at this time based on available information.Alcohol containing hand sanitizers Blood methanol induced blindness and deathRegulatory actions taken.For additional details, refer...
by Pill Pals | Mar 5, 2025 | News
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause...
by Pill Pals | Mar 5, 2025 | News
AcetaminophenStevens-Johnson SyndromeFDA is evaluating the need for regulatory action.Ajovy (fremanezumab-vfrm)Vyepti (eptinezumab-jjmr)Anaphylactic reaction The “Contraindications”, “Warnings and Precautions”, “Adverse Reactions”, and “Patient Counseling Information”...